Techniques have been developed to measure FdUMP, the active metabolite of 5-FUra; thymidylate synthetase (TMP synthase; 5,10-methylenetetrahydrofolate:dUMP C-methyltransferase, EC 2.1.1.45), the target enzyme for this antimetabolite; and dUMP, the substrate that competes with FdUMP for binding to TMP synthetase. As The methods described are sufficiently sensitive to allow these biochemical parameters of 5-FUra action to be measured in cell culture or in needle biopsy samples of human tumors.
Cultured CCRF-CEM human lymphoblastic leukemia cells formed high levels of FdUMP (2.6 nmol per 109 cells) within 11 hr after exposure to 30 ,uM 5-FUra. Tumor cell TMP synthetase levels dropped, and then free FdUMP appeared. The intracellular dUMP pool was low (2) (3) (4) (5) nmol per 109 cells) in logarithmically growing cultures of several tumor cell lines but expanded rapidly in CCRF-CEM cells on exposure to 5-FUra after enzyme levels decreased. The levels of dUMP found after exposure to 5-FUra are sufficient to severely retard inhibition of TMP synthetase by FdUMP.
The methods described are sufficiently sensitive to allow these biochemical parameters of 5-FUra action to be measured in cell culture or in needle biopsy samples of human tumors.
5-Fluorouracil is widely used either as a single agent or in combination with other drugs in the treatment of carcinomas of the breast, ovary, and gastrointestinal tract (1) . Such chemotherapy will induce objective responses in approximately 30% of patients with disseminated breast cancer, and the survival time of responding patients is more than doubled by this drug (2) . Although 5-FUra will produce objective responses in about 20% of patients with gastrointestinal cancer, the effect of this drug on patient survival remains unclear (3, 4) . However, the majority of patients with these diseases do not experience prolongation of life due to 5-FUra therapy; yet they undergo toxicity and, in addition, cannot be treated with alternate drug therapies until failure on treatment protocols involving 5-FUra is confirmed. Hence, it would be invaluable to the improved clinical use of this drug if the tumors that would ultimately respond to 5-FUra could be distinguished from nonresponding neoplasms at an early stage in chemotherapy on the basis of some biochemical parameter or set of parameters of critical importance to successful chemotherapy with this agent. Such a test would be most useful if it were sensitive enough to be performed with specimens from needle biopsies of tumors.
The chemotherapeutic effects of 5-FUra are thought to be primarily due to inhibition of thymidylate synthetase (TMP synthase; 5,10-methylenetetrahydrofolate:dUMP C-methyltransferase, EC 2.1.1.45)'by its 2'-deoxy-5'-monophosphate (FdUMP) (1) . FdUMP has been shown to form a covalent complex with TMP synthetase in the presence of 5,10-methylenetetrahydrofolate (5,10-CH2-H4PteGlu), the folate cofactor for the synthesis of thymidylate (5, 6) . The ability of FdUMP to form this titrating complex has been shown to be decreased in the presence of dUMP (7), the cellular pools of which expanded significantly after 5-FUra treatment in P1534 mouse leukemia (8) and in mouse colon tumors 38 and 51 in vivo (9) . Accumulation of the dUMP pool was not as extensive in the L1210 or W256 tumors (10) . We now report the development and initial application of ultrasensitive techniques for the measurement of FdUMP, TMP synthetase, and dUMP in sufficiently small quantities of tissue to allow assay of these variables in small tumor biopsies.
MATERIALS AND METHODS
Methotrexate-resistant Lactobacillus casei (L. casei/MTX) (11) cells were grown in a 2000-liter fermenter in minimal media (12) . Sonicates of these cells were treated with RNase, DNase, and (NH4)2SO4 (12); then they were chromatographed on phosphocellulose (13) . TMP synthetase was eluted from this column by 0.125 M phosphate, pH 7.1, at a specific activity (3.5 units/mg of protein) indistinguishable from that of twice crystallized enzyme (12) . Highly purified dihydrofolate reductase (1.1 units/mg of protein) eluted from this column with 0.05 M phosphate, pH 7.1. Published methods were used for the assay of TMP synthetase (14) and dihydrofolate reductase (15) during enzyme purification. Protein was measured by the biuret (16) or Hartree (17) method. The concentration of pure solutions of TMP synthetase was determined by using E272 = 105,000 cm-1M-1 (18) or by spectrophotometric assay, assuming a specific activity of 3.5 Dihydrofolate was prepared by reduction of folate with sodium dithionite and purified by repeated crystallizations (19 (22) . FdUMP was either purchased from Sigma or was a gift from Peter Danenberg of this university; material from either source produced identical results.
[14C]Formaldehyde (35-58 mCi/mmol, New England Nuclear) was passed through a column of DEAE-cellulose in acetate form (0.6 X 3 cm) before use. 5,10-14CH2-H4PteGlu was prepared by adding [14C]formaldehyde (usually 0.4 Mmol, 35-58 mCi/mmol) and MgCl2 (130 Amol) to an ampoule containing 6.2 Mmol of tetrahydrofolate in a total volume of 1.7 ml and incubating the mixture for 15 min at room temperature. A charcoal suspension was prepared by mixing 10 g of acidwashed activated charcoal (Sigma) with 2.5 g of bovine serum albumin (Sigma), 0.25 g of high-molecular-weight dextran (T-70, Pharmacia, Uppsala, Sweden), and 100 ml of ice-cold water. This suspension was diluted 1:5 before use. All assays were performed in 15-ml plastic centrifuge tubes (Corning) to minimize surface adsorption.
TMP Synthetase Binding Assay. A standard or unknown quantity of TMP synthetase was mixed in each tube with 6.25 nmol of 5,10-CH2-H4PteGlu (in 25 ,u of buffer A) and 6 pmol of [3H]FdUMP (22 Ci/mmol) in a total volume of 125 ,l. After 20 min of incubation at 300C, 1 ml of ice-cold charcoal suspension per tube was added, the suspensions were mixed, and the tubes were centrifuged immediately for 20 min at 4400 X g. A 0.9-ml portion of the supernate was assayed for radioactivity in 8.1 ml of scintillation cocktail (RIA-II, Research Products International, Elk Grove, IL).
Competitive Ligand Binding Assay for FdUMP. 5,10-CH2-H4PteGlu (8.7 nmol in 25 ,ul of buffer A) was added to 0.6 pmol of [3H]FdUMP (22 Ci/mmol) and a standard or unknown quantity of FdUMP in a total volume of 175 Al. The tubes were mixed and centrifuged at 3000 rpm for 3 min. Pure L. caseil MTX TMP synthetase (0.15 pmol t0.3 pmol of FdUMP binding sites) was added to each tube, and the tubes were incubated at 30'C for 2 hr. The charcoal suspension (1 ml per tube) was added, the tubes were mixed and centrifuged at 4400 X g for 20 min, and 0.9 ml of each supernate was removed for assay by scintillation counting. Some tubes were incubated with less than 90 ± 2.2% of applied dUMP and no more than 1.9 ± 0.5% of applied FdUMP were eluted by 100 mM buffer, and the 300-mM wash contained no more than 7.5 ± 2.2% dUMP and no less than 98 ± 0.8% FdUMP, respectively. At least 16 ml of a cell extract (see below) can be applied to a column after dilution such that the conductivity was 1 mmho without altering this separation.
Cell Culture Conditions. Cells were thawed from mycoplasma-free frozen stocks at 2.5-month intervals and were routinely checked for contamination. All lines were grown in suspension culture in RPMI 1640 medium supplemented with 10% fetal calf serum. For assay of TMP synthetase, cells were disrupted by sonication in 50 mM phosphate, pH 7.4, containing 0.25 M sucrose, and the sonicates were centrifuged at 105,000 X g for 1 hr. Acid-soluble extracts were prepared by the acetic acid method of Nazar et al. (25) . (Fig. 2) . Typically, standard curves were linear from 10 to 5000 pmol. As little as 10 pmol of dUMP was measured reliably in crude tissue extracts (Fig. 2 inset) . However, assays of dUMP fractions of DEAE-cellulose/bicarbonate minicolumns (see below) were usually characterized by lower variability between replicates than that seen with crude extracts (Fig. 2 inset) nmol per assay, respectively (Fig. 4) . UMP, CMP, dCMP, and methotrexate did not affect this competitive ligand binding assay at levels as high as 100 nmol per assay. Although dihydrofolate interfered with the method at 100 nmoles per assay, such an effect is negligible, because dihydrofolate and its polyglutamyl forms are present in tumors at very low concentrations (26) and, in addition, would be destroyed during the aerobic extraction procedure (27) .
RESULTS

Separation of
Rapid Separation of dUMP and FdUMP. The difference in acidity between nitrogen 3 of FdUMP (pKa = 8.0) and that of dUMP (pKa = 9.5) has been exploited to separate these compounds on columns of DEAE-cellulose (28) . When this procedure was adapted to 3-cm columns of DEAE-cellulose packed in pasteur pipets or-plastic pipet tips, it was found that dUMP and FdUMP can be quantitatively separated by batch elution with either ammonium borate, pH 8.0, or ammonium bicarbonate, pH 8.0 . TMP eluted coincidently with dUMP on these columns. When the FdUMP fraction of a HeLa cell extract from an ammonium bicarbonate minicolumn separation was reconstituted and tested in the FdUMP assay system, no interference with the assay by tissue extract was found.
TMP Synthetase, dUMP, and FdUMP in 5-FUra-Treated CCRF-CEM Cells. The time course of TMP synthetase, dUMP, and FdUMP levels in CCRF-CEM cells after exposure to 30 nM 5-FUra is shown in Fig. 5 . At this concentration, the growth of these cells was inhibited within 8 hr (Fig. 5B inset) . Assays for dUMP and FdUMP were performed after fractionation of cell extracts as described above. Inhibition of TMP synthetase resulted in a marked increase in the cellular dUMP pool to levels 300 times higher than basal values within 11 hr. dUMP accumulated at a rate of 66 ± 1 nmol/hr per 109 cells after the enzyme was partially inhibited, whereas FdUMP accumulated at a lower rate of 0.27 b 0.08 nmol/hr per 109 cells after an initial lag (two experiments).
DISCUSSION
The technical advances described in this report represent a 100-fold increase in sensitivity in the analysis of dUMP and FdUMP over the methods of Myers et al. (8) [which already have been used for several enlightening studies (7) (8) (9) (10) ] and are a more convenient form of an FdUMP binding assay for TMP synthetase than previously reported (29) . Because the response of human tumors to 5-FUra chemotherapy is less consistent than in animal tumor models, it seems self-evident that the relationship between therapeutic effects and biochemical parameters should be studied primarily in human tumors. Because ethical constraints limit tissue availability to necessary surgical or biopsy material, the high sensitivities of our assays are required to study the response of these parameters to 5-FUra therapy in clinical situations (28) .
The functional importance of dUMP pool expansion (or, indeed, the occurrence of such an expansion as a general phenomenon) as a determinant of tumor sensitivity to 5-FUra is now open to question, because the degree to which dUMP levels increase in various experimental tumors varies considerably (7) (8) (9) (10) . It is clear that dUMP accumulates rapidly in one line of human tumor cells in culture (Fig. 5) . The fact that free intracellular FdUMP coexists with substantial levels of unbound TMP synthetase (Fig. 5) human tumors. The assay technique for dUMP estimation reported here would be able to detect micromolar levels of this metabolite in 50-mg needle biopsies, a concentration which is minimally effective at decreasing the rate of formation of ternary FdUMP-cofactor-enzyme complex in vitro (7) . The baseline levels of dUMP reported here for several lines of rapidly growing mouse and human cells are equivalent to intracellular dUMP concentrations in the range of 5 MAM, in contrast to the findings of other investigators, whose data are consistent with dUMP concentrations in the range of 100-870MgM (7) (8) (9) (10) .
However, the accumulation of dUMP to concentrations exceeding 2 mM in CCRF-CEM cells exposed to 5-FUra is consistent with the levels found by Myers et al. (7, 8) in the P1534 tumor after 5-FUra treatment. In addition, Jackson (31) has recently found basal dUMP levels in Novikoff hepatoma cells similar to those reported here.
Detection and quantitation of TMP synthetase levels on the order of 1 pmol/mg of protein and dUMP and FdUMP levels similar to those that accumulate in CCRF-CEM cells after exposure to 5-FUra can be easily attained with 50-mg quantities of biopsies of human tumor by using these methods (28) .
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